Interleukin 10: Is it good or bad for the kidney?

Citation
Sj. Chadban et Dj. Nikolic-paterson, Interleukin 10: Is it good or bad for the kidney?, NEPHROLOGY, 4(5-6), 1998, pp. 331-338
Citations number
64
Categorie Soggetti
Urology & Nephrology
Journal title
NEPHROLOGY
ISSN journal
13205358 → ACNP
Volume
4
Issue
5-6
Year of publication
1998
Pages
331 - 338
Database
ISI
SICI code
1320-5358(199810/12)4:5-6<331:I1IIGO>2.0.ZU;2-1
Abstract
Interleukin-10 (IL-10) is a cytokine which has been suggested as a possible immunosuppressive treatment for kidney disease. The ability of IL-10 to su ppress antigen presentation to T cells, inhibit the delayed-type hypersensi tivity reaction and to inhibit macrophage production of pro-inflammatory cy tokines provides a logical basis for its use in the treatment of kidney dis ease. With the exception of Th1-mediated crescentic glomerulonephritis, how ever, IL-10 treatment of experimental kidney disease has produced disappoin ting results largely due to its stimulatory effects upon the humoral immune response, macrophage Fc-receptor expression and macrophage proliferation. Paradoxically, there is now evidence to suggest that endogenous production of IL-10 within the kidney may actually contribute to kidney damage through stimulating mesangial proliferation, immune complex deposition and macroph age infiltration. We await the outcome of studies designed to block IL-10 f unction in experimental disease models.